Drug development for the treatment of onchocerciasis: population pharmacokinetic and adverse events modeling of emodepside
<p><strong>Background</strong><br> To accelerate the progress towards onchocerciasis elimination, a macrofilaricidal drug that kills the adult parasite is urgently needed. Emodepside has shown macrofilaricidal activity against a variety of nematodes and is currently under cli...
Main Authors: | Assmus, F, Hoglund, RM, Monnot, F, Specht, S, Scandale, I, Tarning, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2022
|
Similar Items
-
Potential of emodepside for vector-borne disease control
by: Khemrattrakool, P, et al.
Published: (2025) -
POPULATION PHARMACOKINETICS OF ANTIMALARIAL DRUGS IN THE TREATMENT OF PREGNANT WOMEN WITH UNCOMPLICATED MALARIA
by: Tarning, J, et al.
Published: (2010) -
Population pharmacokinetic properties of antituberculosis drugs in Vietnamese children with tuberculous meningitis
by: Panjasawatwong, N, et al.
Published: (2020) -
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis
by: Taylor, MJ, et al.
Published: (2019) -
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
by: Wattanakul, T, et al.
Published: (2022)